Analysts Swing to Diverse Views for Rice Energy Inc. (RICE), Juno Therapeutics, Inc. (JUNO)

Shares of Rice Energy Inc. (NYSE:RICE) opened at $27.73, and ended -0.43% lower at $27.69. Nearly 3.55 million shares were traded by the close, lower than its average daily volume of 4.46 million shares.

Rice Energy Inc. (RICE) Analyst Opinion

Rice Energy Inc. has a consensus hold rating from 20 Wall Street analysts, and the number of shares currently sold short amount to at least 5.13% of shares outstanding. The stock sank -2.74% last month and is up 29.7 this year. Wall Street is only getting more bullish on the stock, with 3 of analysts who cover RICE having a buy-equivalent rating. Analysts have placed a $27.86 price target on Rice Energy Inc., suggesting a 0.61% gain from recent close. It’s currently trading about -6.29% below its 52-week high.

Rice Energy Inc. Earnings Surprise

Rice Energy Inc. (RICE) surprised the stock market in its last reported earnings when it earned $0.2 a piece versus the consensus-estimated $0.14. Its revenue totaled $360.26 million down -8.52% from the previous quarter.

Rice Energy Inc. (NYSE:RICE) Intraday View

This stock (RICE) is ahead of its 52-week low with 51.31%. Its last month’s stock price volatility remained 1.92% which for the week stands at 1.75%. The share price has moved backward from its 20 days moving average, trading at a distance of -1.96% and stays 0.1% away from its 50 days moving average. Over the last five days, shares have managed 0.87% gains and now is up 16.82% since hitting its 200-day moving average of $25.05. Rice Energy Inc. (RICE) has made its way to a 12-month gain of 8.59%.

Turning to Juno Therapeutics, Inc. (NASDAQ:JUNO), its shares were trading at $43.08 a gain of $0.04, on the trading floor. The stock, after opening at $43.3, touched a high of $43.92 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Juno Therapeutics, Inc. has 5 buy ratings, 5 holds and 0 sells even after the stock tumbled -8.4% from its high of $47.03 to a $4.83 billion market value through last close.

Juno Therapeutics, Inc. (JUNO) Consensus Price Target

The company’s consensus rating on Reuter’s scale improved from 1.92 to 2 during a month. Analysts set a 12-month price target of $39.06 a share. The target implies a -9.33% decrease from where the shares are currently trading. Also, the current price highlights a discount of 29.99% to analysts’ high consensus price target.

Juno Therapeutics, Inc. (NASDAQ:JUNO) Intraday Trading

The counter witnessed a trading volume of 0.97 million shares versus an average volume of 2.61 million shares during last trading session. Its last month’s stock price volatility remained 3.95% which for the week approaches 4.52%. The lowest price the stock reached in the last trading day was $42.82 and compares with the $17.52 52-week low. The stock recovered 145.89% since its low point and has performed 128.54% year-to-date.

Previous articleAnalyst Opinion On How To Bet On Energy Transfer Equity, L.P. (ETE), Nektar Therapeutics (NKTR)
Next articleVaried Analyst Comments On Prologis, Inc. (PLD), Kura Oncology, Inc. (KURA)